Narcolepsy Treatment Guidelines

First-Line Treatments for Adults

• The American Academy of Sleep Medicine strongly recommends modafinil, pitolisant, and sodium oxybate as first-line treatments for symptom control in adults with narcolepsy 1, 2, 3
• Modafinil is strongly recommended with typical dosing of 200-400 mg daily, taken in the morning, and has benefits including significant improvement in excessive daytime sleepiness, disease severity, and quality of life 1
• Pitolisant is strongly recommended for adults and has benefits including clinically significant improvements in excessive daytime sleepiness, cataplexy, and disease severity 1
• Sodium oxybate is strongly recommended for adults and effectively treats both excessive daytime sleepiness and cataplexy, with a caution for CNS depression and respiratory depression 1, 3

First-Line Treatments for Pediatric Patients

• The American Academy of Sleep Medicine conditionally recommends modafinil for pediatric narcolepsy, with a starting dose of 100 mg once upon awakening and a caution for Stevens-Johnson syndrome and psychosis 4
• Sodium oxybate is conditionally recommended for pediatric narcolepsy, with benefits including clinically significant improvements in cataplexy, disease severity, and excessive daytime sleepiness 4

Second-Line and Adjunctive Treatments

• Antidepressants, including tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors, may be used for cataplexy 2, 5
• Methylphenidate may be used as a traditional stimulant, with a caution for higher abuse potential compared to modafinil 4

Monitoring and Follow-up

• The American Academy of Sleep Medicine recommends using standardized assessment tools like the Epworth Sleepiness Scale to quantify sleepiness and monitor treatment response 5
• More frequent follow-up is recommended when starting medications or adjusting doses, and monitoring for adverse effects of stimulants at each visit is necessary 5

Special Considerations

• Inadequate dosing or premature discontinuation due to initial side effects should be avoided, as narcolepsy is a lifelong disorder requiring ongoing management 1, 5

First-Line Therapy for Narcolepsy

Critical Monitoring Considerations

• The American Academy of Sleep Medicine recommends monitoring for Stevens-Johnson syndrome, a rare but serious adverse effect, particularly in younger patients, when using modafinil 6